FDA Moves to Reevaluate Several Peptides American Med Spa Association BPC 157 FDA approval status 2026: Is it legal? Veedma BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with The FDA just changed the game for peptides. April 2026 The FDA is reviewing Category 2 peptides for potential removal from restricted status. Full approval for some peptides may be BPC 157 Explained: Benefits, Safety & Oral vs Injectable Options